Publication | Open Access
THBS2, a microRNA‑744‑5p target, modulates MMP9 expression through CUX1 in pancreatic neuroendocrine tumors
19
Citations
34
References
2020
Year
Pnet CellsImmunologyCancer BiologyTumor BiologyPnet TissuesTranscriptional RegulationSignaling PathwayPancreatic CancerCancer Cell BiologyMicrorna‑744‑5p TargetRadiation OncologyCell SignalingCancer ResearchMolecular SignalingPancreatic Neuroendocrine TumorsGene ExpressionEpigenetic RegulationCell BiologyMicrorna DetectionMmp9 ExpressionMolecular MedicineImmune Cell DevelopmentNatural SciencesTumor SuppressorPnet ProliferationMedicineCell Development
The underlying molecular mechanisms of pancreatic neuroendocrine tumor (pNET) development have not yet been clearly identified. The present study revealed that thrombospondin 2 (THBS2) was downregulated in pNET tissues and cells. Forced expression of THBS2 inhibited the proliferation and migration of pNET cells in vitro. MicroRNA(miR)‑744‑5p was indicated to be a direct regulator of THBS2. Upregulation of miR‑744‑5p potentially caused THBS2 repression. Furthermore, THBS2 inhibited the production of matrix metalloproteinase (MMP) MMP9 through suppressing the transcriptional activity of CUT‑like homeobox 1 (CUX1). CUX1 and MMP9 mediated the effect of THBS2 on pNET proliferation and migration, respectively. The results of the present study revealed a mechanistic role for THBS2 in pNET proliferation and migration, indicating that THBS2 was downregulated by miR‑744‑5p and further affected the CUX1/MMP9 cascade, which promoted the development of pNET.
| Year | Citations | |
|---|---|---|
Page 1
Page 1